EIGER BIOPHARMACEUTICALS

eiger-biopharmaceuticals-logo

Eiger BioPharmaceuticals is a privately held biotechnology company that develops a novel antiviral therapy for Hepatitis Delta, a life-threatening, Orphan Disease with high unmet medical need and no approved therapy. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Its strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients.

#SimilarOrganizations #People #Financial #Event #Website #More

EIGER BIOPHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2008-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.eigerbio.com

Total Employee:
11+

Status:
Active

Contact:
(650)272-6138

Email Addresses:
[email protected]

Total Funding:
156.26 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.


Current Advisors List

paul-f-truex_image

Paul F. Truex Observer @ Eiger BioPharmaceuticals
Board_observer

edgar-g-engleman_image

Edgar G. Engleman Director and Managing Partner @ Eiger BioPharmaceuticals
Board_member

nina-kjellson_image

Nina Kjellson Board Member @ Eiger BioPharmaceuticals
Board_member

Current Employees Featured

not_available_image

Curtis Scribner
Curtis Scribner Vice President, Regulatory @ Eiger BioPharmaceuticals
Vice President, Regulatory

not_available_image

Henk Kocken
Henk Kocken Vice President Quality Assurance @ Eiger BioPharmaceuticals
Vice President Quality Assurance
2021-01-01

not_available_image

Jeffrey Glenn
Jeffrey Glenn Director, Founder @ Eiger BioPharmaceuticals
Director, Founder

christopher-kurtz_image

Christopher Kurtz
Christopher Kurtz Chief Technical Officer @ Eiger BioPharmaceuticals
Chief Technical Officer
2022-04-01

david-cory_image

David Cory
David Cory President and Chief Executive Officer, Board Director @ Eiger BioPharmaceuticals
President and Chief Executive Officer, Board Director

not_available_image

Erik Atkisson
Erik Atkisson General Counsel & Chief Compliance Officer @ Eiger BioPharmaceuticals
General Counsel & Chief Compliance Officer
2021-01-01

not_available_image

Shelly Xiong
Shelly Xiong Vice President, Regulatory Affairs @ Eiger BioPharmaceuticals
Vice President, Regulatory Affairs

kevin-kaster_image

Kevin Kaster
Kevin Kaster Vice President, Patents and Licensing @ Eiger BioPharmaceuticals
Vice President, Patents and Licensing

sarah-mathieson_image

Sarah Mathieson
Sarah Mathieson Senior Vice President, Head of Corporate Affairs @ Eiger BioPharmaceuticals
Senior Vice President, Head of Corporate Affairs
2022-04-01

not_available_image

Ingrid Choong
Ingrid Choong Sr. VP, Clinical Development & Operations @ Eiger BioPharmaceuticals
Sr. VP, Clinical Development & Operations
2019-01-01

Founder


not_available_image

Jeffrey Glenn

Stock Details


Company's stock symbol is NASDAQ:EIGR

Acquisitions List

Date Company Article Price
2015-11-18 Celladon Celladon acquired by Eiger BioPharmaceuticals N/A

Investors List

innovatus-capital-partners_image

Innovatus Capital Partners

Innovatus Capital Partners investment in Post-IPO Equity - Eiger BioPharmaceuticals

innovatus-capital-partners_image

Innovatus Capital Partners

Innovatus Capital Partners investment in Post-IPO Debt - Eiger BioPharmaceuticals

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Eiger BioPharmaceuticals

interwest-partners_image

InterWest Partners

InterWest Partners investment in Debt Financing - Eiger BioPharmaceuticals

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - Eiger BioPharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series A - Eiger BioPharmaceuticals

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - Eiger BioPharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series A - Eiger BioPharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Seed Round - Eiger BioPharmaceuticals

Official Site Inspections

http://www.eigerbio.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.31 K

  • Host name: 104.26.7.198
  • IP address: 104.26.7.198
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Eiger BioPharmaceuticals" on Search Engine